# Remote Monitoring and Optimization of Heart Failure Therapy

Study · id `cardio:ct-nct07622472` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07622472](<https://clinicaltrials.gov/study/NCT07622472>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07622472

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 800 participants.

## Technical summary

Registry record NCT07622472. Randomized; no masking; primary purpose treatment. Start 2026-10-01 (anticipated); primary completion 2028-08-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 800 participants (planned count; ClinicalTrials.gov record NCT07622472, source copy `cardio:ctgov-nct07622472-2026-10-05`, retrieved 2026-10-26)
- Planned start: 2026-10-01 (anticipated) (ClinicalTrials.gov record NCT07622472, source copy `cardio:ctgov-nct07622472-2026-10-05`, retrieved 2026-10-26)
- Primary completion: 2028-08-01 (anticipated) (ClinicalTrials.gov record NCT07622472, source copy `cardio:ctgov-nct07622472-2026-10-05`, retrieved 2026-10-26)
- Completion: 2029-08-01 (anticipated) (ClinicalTrials.gov record NCT07622472, source copy `cardio:ctgov-nct07622472-2026-10-05`, retrieved 2026-10-26)
- Countries: France; Germany; Italy; Netherlands; Poland; Spain; Sweden; Switzerland; United Kingdom (ClinicalTrials.gov record NCT07622472, source copy `cardio:ctgov-nct07622472-2026-10-05`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07622472-2026-10-05`, retrieved 2026-10-26)

## The registry's words

- Brief title: Remote Monitoring and Optimization of Heart Failure Therapy
- Acronym: REMODEL-HF
- Condition: Heart Failure
- Intervention (Device): Wearable Monitoring Device for Heart Failure
- Lead sponsor: Zoll Medical Corporation
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: Zoll Medical Corporation (`cardio:org-zoll-medical-corporation`)

## Provenance

Content hash: 50087bec49178259600dd3d7d19084eed6034049cfb972d09d82eb888ef8ebd6
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
